Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about TOMDF
Recent news which mentions TOMDF
Most Active On The OTC Markets In September – A Look Back As October Comes To A Close
October 27, 2022
Tickers
ADRNY
AKZOY
BASFY
BLGO
Tags
OTCM
ADRNY
Small Cap
From
Benzinga
A Quick Look At The OTC Markets' Most-Active Securities In August - Here's What You Need to Know
September 12, 2022
Tickers
ABML
ADDYY
BASFY
BFFAF
Tags
DANOY
HGTXU
SNWGF
From
Benzinga
Meet The Company Developing Advanved Blood Tests To Detect Cancer And Other Diseases
August 11, 2022
Tickers
TOMDF
Tags
Biotech
Benzinga
Penny Stocks
From
Benzinga
Todos Medical Receives New FDA Certificate of Free Sale for Tollovid® Max Strength including 5 Day Dosing, 30 Day Dosing And 3CL Protease (3CLpro, Mpro, Nsp5) Inhibitor Claim
May 02, 2022
Tickers
TOMDF
Tags
Market News
Partner Content
General
From
Benzinga
Todos Medical Initiates IRB-Waived Tollovid® Market Research Study And Announces 50% Price Reduction Until May 30th, 2022
April 27, 2022
Tickers
TOMDF
Tags
General
Market News
Partner Content
From
Benzinga
Todos Medical To Present At The Emerging Growth Conference
April 25, 2022
Tickers
TOMDF
Tags
Biotech
Penny Stocks
Benzinga
From
Benzinga
Todos Medical Appoints Philippe Goix As Chief Commercial Officer For Provista Diagnostics
April 21, 2022
Tickers
TOMDF
Tags
Press Releases
Todos Medical
TOMDF
From
Benzinga
Todos Medical Reports 2nd Long COVID Case Study And Launches Website For Physicians And Pediatricians To Indicate Interest In Participating In Tollovid® Long COVID Clinical Study
April 20, 2022
Tickers
TOMDF
Tags
Market News
Partner Content
General
From
Benzinga
Todos Medical Targets Athlete Support with Informed Sport Certification for Tollovid® by LGC Group
April 20, 2022
Tickers
TOMDF
Tags
General
Market News
Partner Content
From
Benzinga
New Study Reportedly Calls Into Question Merck's Ivermectin COVID Off Label Use And May Bolster 3CL Protease Inhibitors Such As Tollovid
April 12, 2022
Tickers
MRK
PFE
TOMDF
Tags
Partner Content
Market News
General
From
Benzinga
Todos Medical Applauds White House Initiative on Long COVID and Announces New Tollovid® US FDA Certificate Of Free Sale With Daily And Acute Dosing On The Label
April 06, 2022
Tickers
TOMDF
Tags
General
Partner Content
Market News
From
Benzinga
Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants
April 04, 2022
Tickers
TOMDF
Tags
Biotech
Benzinga
Penny Stocks
From
Benzinga
UPDATE: Todos Medical Reports Fourth-Quarter And Full-Year 2021 Financial Results And Corporate Updates
April 04, 2022
Tickers
TOMDF
Tags
Press Releases
TOMDF
Todos Medical
From
Benzinga
Todos Medical Reports Fourth-Quarter And Full-Year 2021 Financial Results And Corporate Updates
April 01, 2022
Tickers
TOMDF
Tags
General
Partner Content
Market News
From
Benzinga
Todos Medical Reports Case Study Of Patient With Long COVID
March 31, 2022
Tickers
TOMDF
Tags
General
Partner Content
Market News
From
Benzinga
Billy Blanks® Endorses Todos Medical's Line Of Tollovid® Products
March 28, 2022
Tickers
TOMDF
Tags
Todos Medical
TOMDF
Press Releases
From
Benzinga
Todos Medical To Present At The Proactive One2One Virtual Forum
March 17, 2022
Tickers
TOMDF
Tags
General
Market News
Partner Content
From
Benzinga
Todos Medical Completes Acquisition Of Key Assets And Intellectual Property From NLC Pharma
March 16, 2022
Tickers
TOMDF
Tags
Partner Content
Market News
General
From
Benzinga
Todos Medical To Present At The Emerging Growth Conference
March 15, 2022
Tickers
TOMDF
Tags
General
Partner Content
Market News
From
Benzinga
Todos Medical Appoints Greg Meiselbach As Vice President Of Government Affairs
March 08, 2022
Tickers
TOMDF
Tags
Biotech
Benzinga
Penny Stocks
From
Benzinga
These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
February 14, 2022
Tickers
BNPQY
CYDY
EEENF
ETHE
Tags
CYDY
Partner Content
OFSTF
From
Benzinga
Benzinga Announces This Week's All Access Guests
February 10, 2022
Tickers
FBIO
JUPW
LWLG
MDGS
Tags
Market News
Benzinga All Access
FBIO
From
Benzinga
Abbott Labs Outlook Cools the Omicron Led Testing Boom
January 28, 2022
Tickers
ABT
CODX
LH
MRK
Tags
Todos Medical
TOMDF
Health Care
From
Benzinga
Todos Medical And NLC Pharma Announce Primary And Secondary Endpoints Met In NLC-V-01 Phase 2 Clinical Trial Of Oral Antiviral 3CL Protease Inhibitor Tollovir™ In The Treatment Of Hospitalized COVID-1
January 27, 2022
Tickers
TOMDF
Tags
Partner Content
Market News
General
From
Benzinga
Todos Medical Announces Data Lock in Tollovir™ Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients
January 24, 2022
Tickers
TOMDF
Tags
Biotech
Benzinga
Penny Stocks
From
Benzinga
PEPPERDINE UNIVERSITY HOSTS THE 22ND ANNUAL CELEBRITY FLAG FOOTBALL CHALLENGE®, PRESENTED BY TODOS MEDICAL'S TOLLOVID®
January 19, 2022
Tickers
TOMDF
Tags
TOMDF
Todos Medical
Benzinga
From
Benzinga
Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies
January 18, 2022
Tickers
MRK
PFE
TOMDF
Tags
PFE
Biotech
Benzinga
From
Benzinga
Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022
January 12, 2022
Tickers
TOMDF
Tags
General
Partner Content
Market News
From
Benzinga
Todos Medical CEO to Appear on Fox Business to Talk COVID Testing & Tollovir™ on Tuesday, January 11, 2022 and is Presenting at Biotech Showcase 2022
January 11, 2022
Tickers
TOMDF
Tags
Press Releases
Todos Medical
TOMDF
From
Benzinga
Todos Medical to Present at January 5, 2022 Emerging Growth Conference
January 03, 2022
Tickers
TOMDF
Tags
Press Releases
Todos Medical
TOMDF
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.